Q60.6 Potter's syndrome

Name of the Condition

• Potter's syndrome

Summary

Potter's syndrome is a congenital condition characterized by severe oligohydramnios (low amniotic fluid) due to bilateral renal agenesis or severe renal dysplasia, leading to a distinct set of physical abnormalities. The condition arises during fetal development and is associated with pulmonary hypoplasia (underdeveloped lungs) and characteristic facial and limb deformities. It is typically diagnosed prenatally and is incompatible with life due to respiratory failure.

Causes

The primary cause of Potter's syndrome is the absence or severe underdevelopment of both kidneys, which prevents urine production and leads to oligohydramnios. This disrupts normal fetal development, particularly lung growth. While specific causes are often not identifiable, genetic factors (e.g., mutations in renal development genes) and environmental influences during pregnancy may contribute. The condition may also occur as part of genetic syndromes.

Risk Factors

• Family history of congenital kidney defects.
• Genetic syndromes associated with renal anomalies (e.g., VACTERL association).
• Maternal exposure to teratogens or certain medications during pregnancy.

Symptoms

• Severe oligohydramnios detected prenatally.
• Pulmonary hypoplasia causing respiratory distress.
• Physical features of Potter sequence: flattened facies, low-set ears, limb deformities, and positional abnormalities (e.g., clubfoot).

Diagnosis

Diagnosis is typically made prenatally via ultrasound, which reveals oligohydramnios and absent or dysplastic kidneys. Postnatal confirmation involves physical examination of characteristic deformities and imaging (e.g., renal ultrasound) to assess kidney structure. Genetic testing may be considered if a syndrome is suspected.

Treatment Options

There is no cure for Potter's syndrome, as it is incompatible with life. Management focuses on supportive care, including respiratory support for the infant. Prenatal interventions (e.g., amnioinfusion) are not effective for long-term survival.

Prognosis and Follow-Up

The prognosis is universally fatal, with most infants dying shortly after birth due to pulmonary hypoplasia. Follow-up is not applicable for surviving infants, as the condition is not compatible with life.

Complications

• Respiratory failure due to pulmonary hypoplasia.
• Severe physical deformities affecting mobility and function.
• Inability to survive beyond the neonatal period.

Lifestyle & Prevention

No lifestyle modifications can prevent Potter's syndrome, as it is a congenital condition. Prenatal care, including avoiding teratogens and managing maternal health, may reduce risk in subsequent pregnancies.

When to Seek Professional Help

Prenatal care providers should monitor for signs of oligohydramnios or renal abnormalities during routine ultrasounds. Immediate medical evaluation is required if fetal distress or abnormal development is suspected.

Tips for Medical Coders

When coding for Potter's syndrome (Q60.6), ensure documentation confirms bilateral renal agenesis or severe dysplasia with associated oligohydramnios and Potter sequence features. Code Q60.6 is specific to Potter's syndrome and should not be used for unilateral renal agenesis or other renal defects. Verify that clinical notes support the diagnosis to avoid miscoding.